2014年

  1. Takaki, H., K. Honda, K. Atarashi, F. Kobayashi, T. Ebihara, H. Oshiumi, M. Matsumoto, M. Shingai, and T. Seya. 2014. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. Molec. Immunol. 57: 100-110.
  2. Shime, H., A. Kojima, A. Maruyama, Y. Saito, H. Oshiumi, M. Matsumoto, and T. Seya. 2014. Myeloid-derived suppressor cells confer tumor-suppressive functions on natural killer cells via polyinosinic:polycytidylic acid treatment in mouse tumor models. J. Innate Immun. 6: 293-305.
  3. Okamoto, M., H. Oshiumi, M. Azuma, N. Kato, M. Matsumoto, and T. Seya. 2014. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection. J. Immunol. 192: 2770-2777.
  4. Kasamatsu, J., M. Azuma, H. Oshiumi, Y. Morioka, M. Okabe, T. Ebihara, M. Matsumoto, and T. Seya. 2014. INAM Plays a Critical Role in IFN-γ Production by NK Cells Interacting with Polyinosinic-Polycytidylic Acid-Stimulated Accessory Cells. J. Immunol. 193: 5199-207.
  5. Ishii, N., K. Funami, M. Tatematsu, T. Seya, and M. Matsumoto. 2014. Endosomal Localization of TLR8 Confers Distinctive Proteolytic Processing on Human Myeloid Cells. J. Immunol. 193: 5118-28.
  6. Nakai, M., T. Seya, M. Matsumoto, K. Shimotohno, N. Sakamoto, and H. H Aly. 2014. The J6JFH1 strain of hepatitis C virus infects human B-cells with low replication efficacy. Viral Immunol. 27: 285-294.
  7. Kumeta H, H. Sakakibara, Y. Enokizono, K. Ogura, M. Horiuchi, M. Matsumoto , T. Seya, and F. Inagaki. 2014. The N-terminal domain of TIR domain-containing adaptor molecule-1, TICAM-1. J Biomol NMR. 58: 227-230.
  8. Takaki, H., H. Oshiumi, M. Matsumoto, and T. Seya. 2014. Dendritic cell subsets involved in type I IFN induction in mouse measles virus infection models. Int J Biochem Cell Biol. 53C: 329-333.
  9. Tatematsu, M., T. Seya, and M. Matsumoto. 2014. Beyond double-stranded RNA: TLR3 signaling in RNA-induced immune responses. Biochem. J. 458: 195-201.
  10. Seya, T. 2014. Measles virus takes a two-pronged attack on PP1. Cell Host Microbe. 16: 1-2.
  11. Matsumoto, M., K. Funami, M. Tatematsu, M. Azuma, and T. Seya. 2014. Assessment of the Toll-like receptor 3 pathway in endosomal signaling. Methods. Enzymol. 535: 149-165.

2013年

  1. Toscano, F., Y. Estornes, F. Virard, A. Garcia-Cattaneo, A. Pierrot, B. Vanbervliet, M. Bonnin, M. J. Ciancanelli, S. Y. Zhang, K. Funami, T. Seya, M. Matsumoto, J. J. Pin, J. L. Casanova, T. Renno, and S. Lebecque. 2013. Cleaved/associated TLR3 represents the primary form of the signaling receptor. J Immunol. 190: 764-773.
  2. Tatematsu, M., F. Nishikawa, T. Seya, and M. Matsumoto. 2013. Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA. Nat Commun. 4:1833.
  3. Enokizono, Y., H. Kumeta, K. Funami, M. Horiuchi, J. Sarmiento, K. Yamashita, D. Standley, M. Matsumoto, T. Seya, F. Inagaki. 2013. Structures and interface mapping of the Toll/Interleukin-1 receptor-domain-containing adaptor molecules involved in interferon signaling. Proc Natl Acad Sci USA.110: 19908-19913.
  4. Oshiumi, H., M. Miyashita, M. Matsumoto, and T. Seya. 2013. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog. 9 (8): e1003533.
  5. Nishitsuji, H., K. Funami, Y. Shimizu, S. Ujino, K. Sugiyama, T. Seya, H. Takaku, and K. Shimotohno. 2013. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells. J Virol. 87: 8169-8178.
  6. Tanaka, Y., T. Suenaga, M. Matsumoto, T. Seya, and H. Arase. 2013. Herpesvirus 6 Glycoproteins B (gB), gH, gL and gQ are necessary and sufficient for cell-to-cell fusion. J. Virol. 87: 10900-10903.
  7. Takaki, H., M. Takeda M. Tahara, M. Shingai, H. Oshiumi, M. Matsumoto, and T. Seya. 2013. MyD88 pathway in murine CD4+ and plasmacytoid dendritic cells triggers interferon-b production leading to protection against measles in a murine model. J. Immunol. 191: 4740-4747.
  8. Suzuki, T., H. Oshiumi, M. Miyashita, H. H. Aly, Matsumoto, and T. Seya. 2013. Cell type-specific subcellular localization of phospho-TBK1 in response to cytoplasmic viral DNA. PLoS ONE. 8(12): e83639.
  9. Kodama, K., M. Higashiyama, J. Okami, T. Tokunaga, A. Fujiwara, K. Nishiyama, T. Akazawa, and T. Seya. 2013. A possible abscopal effect of post-radiation immunotherapy in two patients with metastatic lung tumors. Int. J. Conf. J. s13691.
  10. Oshiumi, H., H. H. Aly, M. Azuma, M. Matsumoto, and T. Seya. 2013. Multi-step regulation of interferon induction by hepatitis C virus. Arch Immunol Ther Exp. . 61: 127-138.
  11. Seya, T., M. Azuma, and M. Matsumoto. 2013. Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer. Exp Opn Ther Targets. 17: 533-544.
  12. Matsumoto, M., K. Funami, H. Oshiumi, and T. Seya. 2013. Toll-IL-1 receptor-containing adaptor molecule-1: a signaling adaptor linking innate immunity to adaptive immunity. Prog Mol Biol Transl Sci. 117: 487-510.
  13. Kasamatsu, J. 2013. Innate and adaptive pathogen recognition receptors in jawless vertebrates. Microbiol. Immunol. 57: 1-12.

2012年

  1. Abe, Y., K. Fujii, N. Nagata, O. Takeuchi, S. Akira, H. Oshiumi, M. Matsumoto, T. Seya, and S. Koike. 2012. Toll-like receptor 3-mediated antivirus response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.J. Virol.86: 185-194.
  2. Shime H., M. Matsumoto, H. Oshiumi, S. Tanaka, A. Nakane, Y. Iwakura, H. Tahara, N. Inoue, and T. Seya. 2012. TLR3/TICAM-1 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci USA. 109: 2066-2071.
  3. Azuma M., T. Ebihara, H. Oshiumi, M. Matsumoto, and T. Seya. 2012. Cross-presentation and antitumor CTL induced by soluble Ag + polyI:C largely depend on the TICAM-1 pathway in mouse CD11c+/CD8α+ dendritic cells. OncoImmunol. 1: 581-594.
  4. Naito AT, Sumida T, Nomura S, Liu ML, Higo T, Nakagawa A, Okada K, Sakai T, Hashimoto A, Hara Y, Shimizu I, Zhu W, Toko H, Katada A, Akazawa H, Oka T, Lee JK, Minamino T, Nagai T, Walsh K, Kikuchi A, Matsumoto M, Botto M, Shiojima I, Komuro I. 2012. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell.149: 1298-1313.
  5. Yamazaki, S., A. Maruyama, K. Okada, M. Matsumoto, A. Morita, and T. Seya. 2012. Dendritic cells from oral cavity induce Foxp3+ regulatory T cells upon antigen stimulation. PLoS ONE . 7(12) e51665.
  6. Oshiumi, H., M. Matsumoto, and T. Seya. 2012. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J. Biochem. (Tokyo) 151: 5-11.
  7. Aly, H. H., K. Shimotohno, M. Hijikata, and T. Seya. 2012. In vitro models for the analysis of HCV life cycle. Microbiol. Immunol. 56: 1-9 (doi: 10.1111).
  8. Seya T., H. Shime, and M. Matsumoto. 2012. TAMable tumor-associated macrophages in response to innate RNA sensing.OncoImmunol. 1: 1000-1001.
  9. Seya, T., H. Shime, H. Takaki, M. Azuma, H. Oshiumi, and M. Matsumoto. 2012. TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis. OncoImmunol. 1: 917-923.
  10. Horiuchi, T., H. Ohi, I. Ohsawa, T. Fujita, M. Matsushita, N. Okada, T. Seya, T. Yamamoto, Y. Endo, M. Hatanaka, N. Wakamiya, M. Mizuno, M. Nakao, H. Okada, H. Tsukamoto, M. Matsumoto, N. Inoue, M. Nonaka, T. Kinoshita. 2012. Guideline for hereditary angioedema (HAE) 2010 by the Japanese Association for Complement Research-secondary publication. Allergol Int. 61(4): 559-562.

2011年

  1. Watanabe, A. M. Tatematsu, K. Saeki, S. Shibata, H. Shime, A. Yoshimura, C. Obuse, T. Seya, and M. Matsumoto. 2011. Raftlin is involved in the nucleocapture complex to induce poly(I:C)-mediated TLR3 activation. J. Biol. Chem. 86:10702-10711.
  2. Yabu, M., H. Shime, H. Hara, T. Saito, M. Matsumoto, T. Seya, T. Akazawa, and N. Inoue. 2011. IL-23-dependent and -independent enhancement pathway of IL-17A production by lactic acid. Int. Immunol. 23: 29-41.
  3. Takaki, H., Y. Watanabe, M. Shingai, H. Oshiumi, M. Matsumoto, and T. Seya. 2011. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential. Molec. Immunol. 48: 497-504.
  4. Sawahata, R., H. Shime, S. Yamazaki, Y. Fujimoto, K. Fukase, T. Akazawa, N. Inoue, M. Matsumoto, and T. Seya. 2011. Failure of mycoplasmal lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2. Microbes Infect. 13:350-358.
  5. Miyashita, M., H. Oshiumi, M. Matsumoto, and T. Seya. 2011. The SKI2-related helicase DDX60 is a novel antiviral factor promoting RIG-I-like receptor-mediated signaling. Molec. Cell. Biol. 31: 3802-3819.
  6. Ogawa, T., S. Tsuji-Kawahara, T. Yuasa, S. Kinoshita, T. Chikaishi, S. Takamura, H. Matsumura, T. Seya, T. Saga, and M. Miyazawa. 2011. Natural killer cells recognize Friend retrovirus infected erythroid progenitor cells through NKG2D-RAE-1 interactions in vivo. J. Virol. 85: 5423-5435.
  7. Yamazaki, S., K. Okada, A. Maruyama, M. Matsumoto, and T. Seya. 2011. TLR2-dependent induction of IL-10 and Foxp3+CD25+CD4+ regulatory T cells prevents effective anti-tumor immunity induced by Pam2 lipopeptides in vivo. PLoS ONE. 6 (4). e18833.
  8. Aly, H. H., H. Oshiumi, M. Matsumoto, K. Shimotohno, T. Wakita, and T. Seya. 2011. Establishing mouse hepatoma cell lines permissive to human hepatitis C virus. PLoS ONE. 6 (6): e21284.
  9. Wakasa, K., H. Shime, M. Kurita-Taniguchi, M. Matsumoto, M. Imamura, and T. Seya. 2011. Development of monoclonal antibodies that specifically interact with necrotic lymphoma cells. Microbiol. Immunol. 55: 373-377.
  10. Seya, T. 2011. ADDENDUM to the paper published in MIMM by Takaki et al. Molec. Immunol. 48: 1589-1590.
  11. Oshiumi, H., M. Okamoto, K. Fujii, T. Kawanishi, M. Matsumoto, S. Koike, and T. Seya. 2011. The TLR3-TICAM-1 pathway is mandatory for innate immune responses to poliovirus infection. J. Immunol.187: 5320-5327.
  12. Sancho-Shimizu, V., R. Perez de Diego, L. Lorenzo, R. Halwani, A. Alangari, S. Fabrega, A. Cardon, J. Maluenda, M. Tatematsu, F. Mahvelati, M. Herman, M. Ciancanelli, Y. Guo, A. Ghadiri, S. Boucheriti, S. Plancoulaine, C. Picard, F. Rosenberg, M. Tardieu, P. Lebon, E. Jouanguy, T. Seya, M. Matsumoto, N. Rezeai, D. Chaussabel, A. Puel, L. Abel, S-Y. Zhang, S. Al-Muhsen, and J-L. Casanova. 2011. Human TRIF deficiency in otherwise healthy patients with herpes simplex encephalitis. J. Clin. Invest.121: 4889-4902.
  13. Itoh, H., A. Watanabe, K. Iwano, K. Funami, T. Seya, and M. Matsumoto. 2011. UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS ONE. 6(12): e28500.
  14. Hazeki, K., Y. Kametani, H. Murakami, M. Uehara, K. Nigorokawa, S. Takasuga, T. Sasaki, M. Matsumoto, T. Seya, and O. Hazeki. 2012. Phosphoinositide 3-kinase controls the intracellular localization of CpG to limit DNA-PKcs-dependent IL-10 production in macrophages. PLoS ONE.6(10): e26836.
  15. Matsumoto, M., H. Oshiumi, and T. Seya. 2011. Antiviral responses induced by the TLR3 pathway. Rev. Med. Virol. 21: 67-77 (review).
  16. Seya T., J. Kasamatsu, M. Azuma, H. Shime, and M. Matsumoto. 2011. Natural killer cell activation secondary to innate pattern sensing. J. Innate Immunity. 3: 264-273.
  17. Wakita, T., T. Suzuki, M. J. Evans, K. Shimotohno, K. Chayama, Y. Matsuura, M. Hijikata, K. Moriishi, T. Seya, N. Enomoto, K. Koike, N. Kato, T. Kanto, and H. Hotta. 2011. Will there be an HCV meeting in 2020: Summary of the 17th International Meeting on Hepatitis C Virus and Related Viruses. Gastroenterology 141: e1-5.